# Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)

> **NCT05269134** · PHASE2 · WITHDRAWN · sponsor: **Adaptive Phage Therapeutics, Inc.**

## Conditions studied

- Prosthetic Joint Infection

## Interventions

- **DRUG:** Bacteriophage
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05269134
- **Lead sponsor:** Adaptive Phage Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-03-27
- **Primary completion:** 2025-07
- **Final completion:** 2027-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor Decision
- **Last updated:** 2023-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05269134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05269134, "Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05269134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*